ArticleESC heart failure2024

Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure.

Patric Karlström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.